SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 21st 2024 with the purchase of 5,650 own shares at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 20th 2024 with the purchase of 10,300 own shares at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 19th 2024 with the purchase of 8,194 own shares at the average price of 10.
The company GR. SARANTIS S.A. announces, according to L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that Mr. Kyriakos Sarantis, Chairman of the Board of Directors and Executive Member of the Board, proceeded on November 15th of 2024 with the purchase of 2,903 common shares in total at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 18th 2024 with the purchase of 9,140 own shares at the average price of 10.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 15th 2024 with the purchase of 8,690 own shares at the average price of 10.
PiC, a top brand globally in health and care, distributed in Greece by Sarantis Group, actively participated for the first time in the 45th Panhellenic Cardiology Congress, held in Hersonissos, Crete. The event gathered over 1,500 participants from both the Greek and international cardiology community.
SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated April 23rd 2024, the Company proceeded on November 14th 2024 with the purchase of 7,036 own shares at the average price of 10.